AstaTech (Chengdu) Biopharmaceutical Corp. – Trademark Portfolio
Entity Type: 99
AstaTech (Chengdu) Biopharmaceutical Corp. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 1 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include AT ASTATECH. The owner is based in Chengdu City, Sichuan,.
No.488,West Section of Kelin Road,
Wenjiang District,
Chengdu City, Sichuan, 610000 , CN
Showing of trademarks Trademarks
Trademark Classifications
AstaTech (Chengdu) Biopharmaceutical Corp.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does AstaTech (Chengdu) Biopharmaceutical Corp. have?
AstaTech (Chengdu) Biopharmaceutical Corp. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does AstaTech (Chengdu) Biopharmaceutical Corp. file in?
AstaTech (Chengdu) Biopharmaceutical Corp. files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 42 (Computer & Scientific). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are AstaTech (Chengdu) Biopharmaceutical Corp.'s most well-known trademarks?
AstaTech (Chengdu) Biopharmaceutical Corp.'s registered trademark portfolio includes well-known marks such as AT ASTATECH. These are among 2 currently registered trademarks in the portfolio.
What is AstaTech (Chengdu) Biopharmaceutical Corp.'s trademark registration success rate?
AstaTech (Chengdu) Biopharmaceutical Corp. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.